CLPT (ClearPoint Neuro, Inc.) Stock Financials & Earnings

CLPTClearPoint Neuro, Inc.

Mkt Cap$340M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$34M

Net Income (TTM)-$23M

EPS (TTM)-$0.84

Free Cash Flow (TTM)-$14M

Gross Margin61.3%

Op. Margin-66.2%

Net Margin-67.4%

FCF Margin-40.3%

P/S Ratio (TTM)9.9x

P/E Ratio (TTM)—

YoY Rev Growth+12.8%

Employees—

Earnings Reports

Next: Q4 2025 · Mar 11

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$5M	$3M	-$4M
Q1 23	$5M	$3M	-$6M
Q2 23	$6M	$3M	-$7M
Q3 23	$6M	$3M	-$5M
Q4 23	$7M	$4M	-$5M
Q1 24	$8M	$5M	-$4M
Q2 24	$8M	$5M	-$5M
Q3 24	$8M	$5M	-$5M
Q4 24	$8M	$5M	-$6M
Q1 25	$8M	$5M	-$6M
Q2 25	$9M	$6M	-$6M
Q3 25	$9M	$6M	-$5M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q4 22	$4M	$974K	$3M
Q1 23	$3M	$3M	$3M
Q2 23	$4M	$3M	$3M
Q3 23	$2M	$3M	$3M
Q4 23	$3M	$3M	$3M
Q1 24	$3M	$3M	$3M
Q2 24	$3M	$3M	$4M
Q3 24	$3M	$3M	$4M
Q4 24	$3M	$3M	$4M
Q1 25	$3M	$4M	$4M
Q2 25	$4M	$3M	$4M
Q3 25	$3M	$3M	$4M

Revenue Segments

Quarter	Biologics And Drug Delivery	Biologics And Drug Delivery - Disposable Products	Capital Equipment And Software	Capital Equipment And Software - Services	Capital Equipment And Software - Systems and Software Products
Q2 24	$4M	$2M	$945K	$258K	$687K
Q3 24	$4M	$2M	$831K	$279K	$552K

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$28M	$10M	$37M
Q1 23	$22M	$10M	$32M
Q2 23	$26M	$0	$26M
Q3 23	$24M	$0	$24M
Q4 23	$23M	$0	$23M
Q1 24	$35M	$0	$35M
Q2 24	$33M	$0	$33M
Q3 24	$22M	$0	$22M
Q4 24	$20M	$0	$20M
Q1 25	$12M	$0	$12M
Q2 25	$42M	$0	$42M
Q3 25	$38M	$0	$38M

Shares Outstanding

Revenue Per Employee

Revenue / Employee